Showing 111-120 of 159 results for "".
- #RealDealAesthetics Takes on Minimally Invasive Body Contouringhttps://practicaldermatology.com/news/realdealaesthetics-takes-on-minimally-invasive-body-contouring/2459934/Save the date: Practical Dermatology®'s sister publication Modern Aesthetics’ newest Tweet chat series -- #RealDealAesthetics -- featuring New York City dermatologist Gary Goldenberg, MD and Charleston, SC dermatologist Todd E. Schlesinger, MD is back. The f
- Whale of a Tale: Shark Gets Botox Injectionshttps://practicaldermatology.com/news/whale-of-a-tale-shark-gets-botox-injections/2457642/It may sound fishy, but even sharks can benefit from Botox injections. Charles E. Crutchfield III, MD, and Crutchfield Dermatology in Eagan, MN recently assisted the veterinary staff at Minnesota Zoo in Apple Valley with a unique patient. Haps, a sand tiger shark, had
- Modern Aesthetics® Set to Launch New Tweet Chat Series-- #RealDealAestheticshttps://practicaldermatology.com/news/modern-aesthetics-set-to-launch-new-tweet-chat-series-realdealaesthetics/2457720/Practical Dermatology’s sister publication, Modern Aesthetics® magazine, is launching a new Tweet chat series --#RealDealAesthetics -- featuring New York City dermatologist Gary Goldenberg, MD and Charleston, SC dermatologist Todd E. Schlesinger, MD. The f
- Aclaris Partners with Cipher to Seek Approval and Commercialize A-101 40% for Seborrheic Keratoses in Canadahttps://practicaldermatology.com/news/aclaris-partners-with-cipher-to-seek-approval-and-commercialize-a-101-40-for-seborrheic-keratoses-in-canada/2457814/Aclaris Therapeutics, Inc., has licensed the Canadian rights to commercialize A-101 40% topical solution for the treatment of raised seborrheic keratoses (A-101 40%) to Cipher Pharmaceuticals. A-101 40% was FDA approved in December 2017 and is marketed by Aclaris in the U.S. under the tradename E
- PuraCap Pharmaceuticals Introduces EpiCeram Quad Packhttps://practicaldermatology.com/news/puracap-pharmaceuticals-introduces-epiceram-quad-pack/2458088/PuraCap® Pharmaceutical is introducing the EpiCeram® Controlled Release Skin Barrier Emulsion Quad Pack, which contains four 100-gram airless pumps. EpiCeram® is a US Food and Drug Administration-approved topical prescription e
- Bonti's Novel Gateway Neuromodulator Performs Well in Phase 2A Studyhttps://practicaldermatology.com/news/bontis-novel-serotype-e-botulinum-toxin-performs-well-in-phase-2a-study/2458094/Bonti’s lead product candidate, EB- 001, passed muster in a Phase 2A study for the treatment of glabellar lines. EB-001 is a novel serotype E botulinum neurotoxin with a unique efficacy profile, characterized by fast onset of action (about 24 hours
- Senate Unveils Health Care Proposalhttps://practicaldermatology.com/news/senate-unveils-health-care-proposal/2458147/The newly unveiled Senate Republican leadership’s health care proposal, the Better Care Reconciliation Act of 2017, would roll back much of the Affordable Care Act (ACA). According to media reports, the 142-page bill calls for: Elimination of the individual and e
- Dermatology Scientist Sarah Millar Receives 2016 Focus Award For The Advancement Of Women In Medicinehttps://practicaldermatology.com/news/dermatology-scientist-sarah-millar-receives-2016-focus-award-for-the-advancement-of-women-in-medicine/2458364/Penn dermatology scientist Sarah E. Millar, PhD received the 2016 FOCUS Award for the Advancement of Women in Medicine. Millar, the Albert M. Kligman Endowed Professor and vice chair for basic science research in the department of Dermatology at the Perelman School of Medicine at the Univ
- Dermatologist Todd Schlesinger to Host Bellafill Discussion Fridayhttps://practicaldermatology.com/news/dermatologist-todd-schlesinger-to-host-bellafill-discussion-friday/2458484/Todd E. Schlesinger, MD, FAAD will host a program on behalf of Suneva, in which he will discuss Suneva's Bellafill® and other products. The event will be held Friday, July 29th, 2016 at 8pm at Towne Stove and Spirits, 900 Boylston Street, Boston. Those interested in atte
- Dr. Bruce Strober Appointed Chair of Dermatology at UConn Healthhttps://practicaldermatology.com/news/dr-bruce-strober-appointed-chair-of-dermatology-at-uconn-health/2458694/Bruce E. Strober, MD, PhD has been appointed chair of the Department of Dermatology at UConn Health and professor of dermatology at UConn School of Medicine. Dr. Strober has served as the interim chair of the Department of Dermatology since 2015 and vice chair since joining UConn Health in 2011.